Bicalutamide is a non-steroidal androgen receptor antagonist used as part of combined androgen blockade in the treatment of prostate cancer. Simson Pharma's Bicalutamide reference standard and impurities support compendial testing for this widely used oncology agent.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bicalutamide Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.